$BNB According to Foresight News, Liminatus Pharma, Inc. (NASDAQ: LIMN), a preclinical-stage biopharmaceutical company, has announced plans to strategically expand into the cryptocurrency and blockchain sectors. The company intends to establish a subsidiary named 'American BNB Strategy' to lead its digital asset investment and management initiatives.